The Uniphar (ISE:UPR) share price has done well in the last month, posting a gain of 31%. While recent buyers might be laughing, long term holders might not be so pleased, since the recent gain only ...

Uniphar is planning to integrate E4H, Devonshire Healthcare Services and Dublin-based Navi Group into its own operations. Dublin-headquartered healthcare services company Uniphar has announced three ...

Uniphar has agreed to certain undertakings pending a hearing in a dispute over an alleged breach of an agreement between the pharma giant and a pharmacy brokerage business, the High Court heard on ...

Based on the one-year price targets offered by 7 analysts, the average target price for Uniphar PLC (DUB:UPR) is $4.83 with a high estimate of $5.00 and a low estimate of $4.50. The average target ...

The CCPC found that Uniphar acquiring Navi would ‘substantially lessen competition’ in Ireland. Uniphar’s proposed acquisition of Irish pharma services group Navi has been blocked by Ireland’s ...

Healthcare services group Uniphar has reported higher profit and revenues for the six months to the end of June and said it remained confident of reaching its target of €200m EBITDA by 2028. Shares in ...

DUBLIN, October 22, 2024--(BUSINESS WIRE)--Healthcare services business, Uniphar, has developed its full-service offering that harnesses Uniphar’s 55 years in the industry delivering specialist ...

Irish pharmaceuticals group Uniphar has completed its acquisition of Durbin, a specialist pharmaceuticals provider based in the UK and the US. Uniphar says Durbin will be integrated into its Product ...

RALEIGH, NC / ACCESSWIRE / June 11, 2024 / Sky Cell AG, founded in Switzerland, continues paving the way for sustainable Pharma Logistics. With an industry-leading temperature excursion rate of less ...

Pharmacy and healthcare services group Uniphar will use the proceeds of its planned stock market flotation to pay for near-term acquisition targets and to reduce its debt levels. The pharmaceutical ...

DUBLIN (Reuters) - Irish pharmaceuticals group Uniphar has hired stockbroker Davy and RBC Capital Markets to sound out investors for a possible initial public offering (IPO) in 2019, a source familiar ...

The Competition Authority announced today (15th July) that it will allow the proposed acquisition by UniPhar plc (the parent company of the UniPhar Group) of Ammado Limited, (the holding company for ...